Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 July 2020 | Story Valentino Ndaba | Photo Anja Aucamp
Dr Fumane Khanare opted to integrate poetry into her teaching practice, using innovative ways to keep the curriculum afloat and interesting at the same time.

The Coronavirus (COVID-19) lockdown has severely affected teaching and learning. Lecturers and students alike have been challenged to explore innovative ways to keep the curriculum afloat and interesting at the same time. Dr Fumane Khanare, Senior Lecturer in the Faculty of Education, has opted to integrate poetry into her teaching practice. Her Community Psychology students have shifted over the past few months from merely interacting with the course material to generating their own content.

Learning in the times of lockdown

According to Dr Khanare, the psycho-social impact of COVID-19 remains unknown as the world grapples with a backlog of information, accompanied by loss and grief. However, collaborative strides are being made in the right direction, considering that this is unchartered territory. “Recommendations advocating for online teaching and learning, bidding for free data, and laptops for the majority of students, especially those at the peripheries of a mainstream economy – and of course physical distancing-adhering wellness programmes – may enable effective teaching and learning.” 

Why poetry?

“Lurched in at the deep end and taking into account the students who are not well-equipped with the integration of information and communications technology in learning, is significant. This realisation led me to seek ways to help my students develop a deeper understanding and critical-thinking skills, as well as becoming self-motivated students amid COVID-19,” explained Dr Khanare.

Students were first tasked with analysing the poetry of Butler-Kisber (2002). Thereafter, they were required to write poems about COVID-19, underpinned by the Community Psychology in Education module. “The activity provided students with an opportunity to use and reinforce concepts learnt prior to the lockdown, monitor their own understanding and progress, plus motivate them to come to the lecture prepared – a function known as co-creators of knowledge,” she said.

The artistic creations of these students were circulated among peers for review, allowing them to move from the peripheries to the centre of knowledge production amid a pandemic. 

Digitising the education space

Beyond the classroom, Dr Khanare will attend the 2020 Women Academics in Higher Education Virtual Symposium. As the co-convener of the World Education Research Association-International Research Network, she continues to ensure that research-related activities continue, despite a ban on international travel.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept